Nuclear cardiology, Part IV: Viability.
After reading Part IV of this series of nuclear cardiology articles, the reader should be able to describe: (a) the differences between SPECT and PET techniques; (b) the various radiopharmaceuticals and imaging protocols used for detecting viability with SPECT; (c) the different radiopharmaceuticals and imaging protocols used for detecting viability with PET; and (d) the imaging patterns observed after reconstructing myocardial images.
Mesotten
L
L
Catholic University of Leuven, Belgium.
Maes
A
A
Hambye
A S
AS
Everaert
H
H
Van den Maegdenbergh
V
V
Franken
P
P
Mortelmans
L
L
D003327:Coronary Disease / Q000000981:diagnostic imaging*; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D017682:Myocardial Stunning / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging*
D019275:Radiopharmaceuticals